APA (7th ed.) Citation

E, E., VD, G., S, C., E, S., K, M., J, S., . . . A, P. (2021). Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction: Are Patients at Risk of Underexposure? European journal of drug metabolism and pharmacokinetics, 46(4), 527. https://doi.org/10.1007/s13318-021-00694-0

Chicago Style (17th ed.) Citation

E, Esteve-Pitarch, et al. "Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction: Are Patients at Risk of Underexposure?" European Journal of Drug Metabolism and Pharmacokinetics 46, no. 4 (2021): 527. https://doi.org/10.1007/s13318-021-00694-0.

MLA (9th ed.) Citation

E, Esteve-Pitarch, et al. "Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction: Are Patients at Risk of Underexposure?" European Journal of Drug Metabolism and Pharmacokinetics, vol. 46, no. 4, 2021, p. 527, https://doi.org/10.1007/s13318-021-00694-0.